GrowingStockReport.com

NASDAQ Active Stock Watch List: Cell Therapeutics, Inc. (NASDAQ:CTIC) and Westport Innovations Inc. (NASDAQ:WPRT) Added to Growing Stock Report's NASDAQ Active Stock Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 12/03/2013 -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding Cell Therapeutics, Inc. (NASDAQ:CTIC) and Westport Innovations Inc. (NASDAQ:WPRT).

Cell Therapeutics, Inc. (NASDAQ:CTIC) a company that acquires, develops, and commercializes treatments for cancer closed up in its previous session (+1.03%) on 3,185,077 shares traded after Cell Therapeutics Received $5 Million Milestone Payment for TRISENOX. Cell Therapeutics, Inc. (NASDAQ:CTIC) is currently up (+111.34%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Cell Therapeutics, Inc. (NASDAQ:CTIC)

Westport Innovations Inc. (NASDAQ:WPRT) a company that provides low-emission engine and fuel system technologies utilizing gaseous fuels closed down in its previous session (-4.24%) on 1,576,187 shares traded. Westport Innovations Inc. (NASDAQ:WPRT) is currently down (-42.01%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Westport Innovations Inc. (NASDAQ:WPRT)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com